Two cancer research studies reveal essential role of neutrophils in immunotherapy

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.

Phase 2 trial data shows durvalumab immunotherapy with standard

Scientists uncover a startling and exploitable coordination of

Second-line cetuximab active beyond progression in quadruple wild

Surprise Finding Shows That Neutrophils Can Be Key Antitumor

Double-edged sword: Killing cancer cells can also drive tumour

Retinol disruption and the role of vitamin a metabolism in colon

ASCO GI: Less chemotherapy may have more benefit in rectal cancer

Chemotherapy for rare cancer fine-tuned with organoids - ecancer

ESMO 2016: Pembrolizumab new option for first line treatment of

Two cancer research studies reveal essential role of neutrophils